SE9402119D0 - Solution - Google Patents

Solution

Info

Publication number
SE9402119D0
SE9402119D0 SE9402119A SE9402119A SE9402119D0 SE 9402119 D0 SE9402119 D0 SE 9402119D0 SE 9402119 A SE9402119 A SE 9402119A SE 9402119 A SE9402119 A SE 9402119A SE 9402119 D0 SE9402119 D0 SE 9402119D0
Authority
SE
Sweden
Prior art keywords
igf
aqueous solution
purity
inert gas
drug product
Prior art date
Application number
SE9402119A
Other languages
English (en)
Inventor
Jonas Fransson
Ulf Nilsson
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Priority to SE9402119A priority Critical patent/SE9402119D0/sv
Publication of SE9402119D0 publication Critical patent/SE9402119D0/sv
Priority to IL11406395A priority patent/IL114063A0/xx
Priority to PCT/SE1995/000685 priority patent/WO1995034318A1/en
Priority to AU27576/95A priority patent/AU2757695A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
SE9402119A 1994-06-16 1994-06-16 Solution SE9402119D0 (sv)

Priority Applications (4)

Application Number Priority Date Filing Date Title
SE9402119A SE9402119D0 (sv) 1994-06-16 1994-06-16 Solution
IL11406395A IL114063A0 (en) 1994-06-16 1995-06-08 Solution comprising IGF-I or any functional analogue thereof and method for its preparation
PCT/SE1995/000685 WO1995034318A1 (en) 1994-06-16 1995-06-08 Solution comprising igf-i or any functional analogue thereof and method for its preparation
AU27576/95A AU2757695A (en) 1994-06-16 1995-06-08 Solution comprising igf-i or any functional analogue thereof and method for its preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9402119A SE9402119D0 (sv) 1994-06-16 1994-06-16 Solution

Publications (1)

Publication Number Publication Date
SE9402119D0 true SE9402119D0 (sv) 1994-06-16

Family

ID=20394415

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9402119A SE9402119D0 (sv) 1994-06-16 1994-06-16 Solution

Country Status (4)

Country Link
AU (1) AU2757695A (sv)
IL (1) IL114063A0 (sv)
SE (1) SE9402119D0 (sv)
WO (1) WO1995034318A1 (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5783556A (en) * 1996-08-13 1998-07-21 Genentech, Inc. Formulated insulin-containing composition
CA2369451C (en) 1999-04-08 2009-09-22 Genentech, Inc. Composition based on oppositely-charged polypeptides
GB2374735B (en) 2001-04-20 2003-10-08 Kettle Solutions Ltd Electrical connector
ES2524516B1 (es) * 2014-05-29 2015-03-31 Grifols Worldwide Operations Limited Procedimiento de preparación de albúmina humana con nivel de oxígeno disuelto reducido

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4727027A (en) * 1983-05-02 1988-02-23 Diamond Scientific Co. Photochemical decontamination treatment of whole blood or blood components
US5272135A (en) * 1991-03-01 1993-12-21 Chiron Ophthalmics, Inc. Method for the stabilization of methionine-containing polypeptides

Also Published As

Publication number Publication date
WO1995034318A1 (en) 1995-12-21
AU2757695A (en) 1996-01-05
IL114063A0 (en) 1995-11-27

Similar Documents

Publication Publication Date Title
CA2161350A1 (en) Oxygen-reduced aqueous solution of factor viii
MXPA03000001A (es) Nuevo metodo para obtener formulaciones acuosas con principios activos susceptibles a oxidacion y las soluciones acuosas obtenidas de este modo.
ATE242015T1 (de) Zusammensetzung und verfahren zur zersetzung von wasserstoffperoxid
CA2161366A1 (en) Meat processing
BR9607922A (pt) Produto medicamentoso final de uma proteína de plasma processos para preparar o produto medicamentoso final para melhorar a estabilidade de longo prazo de uma proteína de plasma e para tratar hemofilia e uso de um produto medicamentoso final
AU3416889A (en) Process for producing liposomes and/or bilological cells, which have included ingredient substances, and their use
EP1163906A3 (en) Method for stabilizing pranoprofen and stable liquid preparation of pranoprofen
SE9402119D0 (sv) Solution
DE602004010817D1 (de) Verfahren zur stabilisierung von atorvastatin
FI925550A0 (fi) Piperidylmetyl-substituerade kromanderivat
UA39178C2 (uk) Спосіб мінімізації деградації активованого протеїну с (варіанти), фармацевтична композиція та водний розчин активованого протеїну с
ES2157806A1 (es) Proceso para desinfectar frutos citricos de plagas de moscas de la fruta.
MXPA05005915A (es) Soluciones de albumina humana terapeutica con baja actividad del activador de precalicreina (pka) y procedimiento de obtencion de las mismas.
MX9700617A (es) Albumina humana terapeutica con baja capacidad para la fijacion de aluminio.